Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
US Department of Justice
Colorcon
Moodys
US Army
Mallinckrodt
Healthtrust
Citi
Farmers Insurance
McKinsey

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,399,101

« Back to Dashboard

Which drugs does patent 6,399,101 protect, and when does it expire?

Patent 6,399,101 protects LEVO-T and is included in one NDA.

This patent has eight patent family members in seven countries.
Summary for Patent: 6,399,101
Title: Stable thyroid hormone preparations and method of making same
Abstract:Provided is a pharmaceutical preparation of thyroid hormone and a process of making a tablet formulation of the pharmaceutical preparation using direct compression. In a preferred embodiment, the pharmaceutical preparation comprises levothyroxine sodium and silicified microcrystalline cellulose.
Inventor(s): Frontanes; Ramon A. (Caguas, PR), Bruno; Maria S. (Guaynabo, PR), Garcia; Hector L. (Cidra, PR), Simamora; Pahala (Cardova, TN), Perez; Maria A. (Aguas Buenas, PR)
Assignee: Mova Pharmaceutical Corp. (Caguas, PR)
Application Number:09/538,461
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Use;

Drugs Protected by US Patent 6,399,101

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-001 Mar 1, 2002 AB1,AB2,AB3 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-002 Mar 1, 2002 AB1,AB2,AB3 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-003 Mar 1, 2002 AB1,AB2,AB3 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-004 Mar 1, 2002 AB1,AB2,AB3 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-005 Mar 1, 2002 AB1,AB2,AB3 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-006 Mar 1, 2002 AB1,AB2,AB3 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-007 Mar 1, 2002 AB1,AB2,AB3 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-008 Mar 1, 2002 AB1,AB2,AB3 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-009 Mar 1, 2002 AB1,AB2,AB3 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-010 Mar 1, 2002 AB1,AB2,AB3 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,399,101

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2001252953 ➤ Sign Up
Australia 5295301 ➤ Sign Up
Brazil 0109736 ➤ Sign Up
Canada 2404369 ➤ Sign Up
European Patent Office 1267999 ➤ Sign Up
Israel 152024 ➤ Sign Up
Japan 2003528931 ➤ Sign Up
World Intellectual Property Organization (WIPO) 0174448 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Teva
Accenture
QuintilesIMS
Daiichi Sankyo
US Department of Justice
Express Scripts
Healthtrust
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot